Human T-cell leukemia virus type 1 blunts signaling by interferon alpha

Virology

Volumn 374, Issue 1, 2008, Pages 210-216

  Feng, Xuan ^a   Ratner, Lee ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gag; HTLV; STAT2; TYK2; Type I interferon

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; PROTEIN KINASE TYK2; RNA POLYMERASE; STAT2 PROTEIN; TAX PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; SIGNAL TRANSDUCTION; VIRUS IMMUNITY;

CELL LINE; GENES, REPORTER; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERFERON-ALPHA; LUCIFERASES; MODELS, BIOLOGICAL; PROTEIN-TYROSINE KINASES; STAT2 TRANSCRIPTION FACTOR; TYK2 KINASE;

ANIMALIA; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 41649105660     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.12.036     Document Type: Article

References (32)

1. Best S.M., Morris K.L., Shannon J.G., Robertson S.J., Mitzel D.N., Park G.S., Boer E., Wolfinbarger J.B., and Bloom M.E. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J. Virol. 79 (2005) 12828-12839
2. Brierley M.M., and Fish E.N. Stats: Multifaceted regulators of transcription. J. Interferon Cytokine Res. 25 (2005) 733-744
3. Dave R.S., McGettigan J.P., Qureshi T., Schnell M.J., Nunnari G., and Pomerantz R.J. siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects. Virology 348 (2006) 489-497
4. Feng X., VanderHeyden N., and Ratner L. Interferon-alpha-inhibits HTLV-1 assembly. J. Virol. 77 (2003) 13389-13395
5. Furuya T., Nakamura F., Fujimoto T., Nakane S., Kambara C., Shirabe S., Hamasaki S., Motomura M., and Eguchi K. Elevated levels of interleukin-12 and interferon-gamma in patients with human T lymphotropic virus type I-associated myelopathy. J. Neuroimmunol. 95 (1999) 185-189
6. Garcia-Sastre A. Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses. Microbes Infect. 4 (2002) 647-655
7. Guo J.T., Hayashi J., and Seeger C. West Nile virus inhibits the signal transduction pathway of alpha interferon. J. Virol. 79 (2005) 1343-1350
8. Heidecker G., Hill S., Lloyd P.A., and Derse D. A novel protease processing site in the transframe protein of human T-cell leukemia virus type 1 PR76(gag-pro) defines the N terminus of RT. J. Virol. 76 (2002) 13101-13105
9. Hishizawa M., Imada K., Kitwaki T., Ueda M., Kadowaki N., and Uchiyama T. Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals. Br. J. Haematol. 125 (2004) 568-575
10. Ho L.J., Hung L.F., Weng C.Y., Wu W.L., Chou P., Lin Y.L., Chang D.M., Tai T.Y., and Lai J.H. Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J. Immunol. 174 (2005) 8163-8172
11. Katze M.G., He Y., and Gale M. Viruses and interferon: a fight for supremacy. Nat. Rev., Immunol. 2 (2002) 675-687
12. Khabara K.S.A., al-Haja L., al-Zoghaibia F., Mariea M., Dhallaa M., Polyakc S.J., and Williams B.R.G. Expressed gene clusters associated with cellular sensitivity and resistant towards anti-viral and anti-proliferation actions of interferon. J. Mol. Biol. 342 (2004) 833-846
13. Kimata J.T., Wong F.-H., Wang J.J., VanderHeyden N., and Ratner L. Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology 204 (1994) 656-664
14. Kovarik P., Mangold M., Ramsauer K., Heidari H., Steinborn R., Zotter A., Levy D.E., Muller M., and Decker T. Specificity of signaling by Stat1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J. 20 (2001) 91-100
15. Levy D.E., and Garcia-Sastre A. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev. 12 (2001) 143-156
16. Li S., Labrecque S., Gauzzi M.C., Cuddihy A.R., Wong A.H., Pellegrini S., Matlashewski G.J., and Koromilas A.E. The human papilloma virus (HPV)-18 E6 oncoprotein physically associated with TYK2 and impairs JAK-STAT activation by interferon-alpha. Oncogene 18 (1999) 5727-5737
17. Lin R.-J., Chang B.-L., Yu H.-P., Liao C.-L., and Lin Y.-L. Blocking of interferon-induced JAK-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism. J. Virol. 80 12 (2006) 5908-5918
18. Marchetti M., Monier M.-N., Fradagrada A., Mitchell K., Baycheliere F., Eid P., Johannes L., and Lamaze C. Stat-mediated signaling induced by type I and type II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin-dependent endocytosis of IFN receptors. Mol. Biol. Cell 17 (2006) 2896-2909
19. Migone T.S., Lin J.X., Cereseto A., Mulloy J.C., O'Shea J.J., Franchini G., and Leonard W.J. Constitutively activated JAK-STAT pathway in T cells transformed with HTLV-I. Science 269 (1995) 79-81
20. Mordechai E., Kon N., Henderson E.E., and Suhadolnik R.J. Activation of the interferon-inducible enzymes, 2′,5′-oligoadenylate synthetase and PKR by human T-cell leukemia virus type I Rex-response element. Virology 206 (1995) 913-922
21. Okumura A., Lu G., Pitha-Rowe I., and Pitha P.M. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. U. S. A. 103 5 (2006) 1440-1445
22. Ramos J.C., Ruiz P., Ratner L., Reis I.M., Brites C., Pedroso C., Byrne G.E., Toomey N.L., Andela V., Harhaj E.W., Lossos I.S., and Harrington W.J. IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma. Blood 109 (2007) 3060-3068
23. Robek M.D., and Ratner L. Immortalization of T-lymphocytes by human T-cell leukemia virus type 1 tax mutants with different trans-activating phenotypes. J. Virol. 73 (1999) 4856-4865
24. Ruckes T., Saul D., Van Snick J., Hermine O., and Grassman R. Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. Blood 98 (2001) 1150-1159
25. Samuel M.A., and Diamond M.S. Pathogenesis of West Nile virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J. Virol. 80 19 (2006) 9349-9360
26. Sen G.C. Viruses and interferons. Annual Review of Microbiology 55 (2001) 255-281
27. Trejo S., and Ratner L. The HTLV receptor is widely expressed. Virology 268 (2000) 41-48
28. Tsukahara T., and Ratner L. Characterization of envelope glycoprotein mutants for HTLV-1 infectivity and immortalization. J. Virol. 75 (2001) 9553-9559
29. vanBoxel-Dezaire A.H.H., Rani M.R.S., and Stark G.R. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25 (2006) 361-372
30. Wesoly J., Szweykowska-Kulinska Z., and Bluyssen H.A.R. Stat activation and differential complex formation dictate selectivity of interferon responses. Acta Biochim. Pol. 54 (2007) 27-38
31. Yamagata T., Nishida J., Tanaka S., Sakai R., Mitani K., Yoshia M., Taniguchi T., Tazaki Y., and Hirai H. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol. Cell. Biol. 16 (1996) 1283-1294
32. Yokosawa N., Indoh T., Kubota T., Yashiki T., and Fujii N. Suppressed induction of 2-5 OAS in cells with HTLV-I is not associated with the fluctuation of IFN-receptor, IFN-regulatory factors (IRF1 and IRF-2) or Stat-1 alpha. Microbiol. Immunol. 41 (1997) 63-66